Expert perspectives on tricuspid repair | replacement | medical therapy - Beyond the guidelines: Insights from the cardiovascular research technologies 2026 meeting [0.03%]
Asa Phichaphop,Gregg W Stone,Maurice Enriquez-Sarano et al.
Asa Phichaphop et al.
Advancements in transcatheter tricuspid valve intervention (TTVI) technology have yielded meaningful improvements in quality-of-life (QOL) for patients with tricuspid regurgitation (TR). The recent Food and Drug Administration (FDA) approva...
Khalid Sawalha,Barry Uretsky
Khalid Sawalha
Device-specific failure patterns of guide catheter extensions in percutaneous coronary intervention: A contemporary MAUDE database analysis (2022-2025) [0.03%]
Own Khraisat,Nouraldeen Manasrah,Mark Amir Mosaad et al.
Own Khraisat et al.
Purpose: To characterize the spectrum and distribution of adverse events and device malfunctions associated with guide catheter extensions (GCEs) reported to the FDA's Manufacturer and User Facility Device Experience (MAU...
Global use of statins and antihypertensives in patients with stage 4 cardiovascular kidney metabolic syndrome [0.03%]
Besir Besir,Osamah Badwan,Issam Motairek et al.
Besir Besir et al.
Background: Cardiovascular-kidney-metabolic (CKM) syndrome is characterized by the interactions among metabolic risk factors, chronic kidney disease (CKD), and cardiovascular disease (CVD). Stage 4 CKM is characterized by...
Response to the comment on our paper "Post-procedural ultrasound findings linked to symptomatic radial artery occlusion following transradial coronary intervention" [0.03%]
Sven M Piepenburg,Dennis Bünte,Derek Hazard et al.
Sven M Piepenburg et al.
Renin-angiotensin system inhibitors use and outcomes of aortic valve replacement: A systematic review and meta-analysis [0.03%]
Muhammad Rafay Shahzad Cheema,Anfal Arshad,Sabahat Ul Ain Munir Abbasi et al.
Muhammad Rafay Shahzad Cheema et al.
Background: Aortic stenosis leads to adverse left ventricular remodeling; aortic valve replacement (AVR) remains the cornerstone of management. We evaluated clinical and echocardiographic outcomes with renin-angiotensin s...
Georgios E Papadopoulos,Ilias Ninios,Sotirios Evangelou et al.
Georgios E Papadopoulos et al.
Background: Mitral transcatheter edge-to-edge repair (M-TEER) effectively reduces mitral regurgitation (MR), yet conventional metrics may incompletely capture myocardial recovery. Myocardial deformation imaging offers qua...
Saline optical coherence tomography in percutaneous coronary intervention: Practical considerations and technical guidance [0.03%]
Bernard Wong,Bharat Khialani,James Xu et al.
Bernard Wong et al.
Optical coherence tomography (OCT) is a high-resolution intravascular imaging modality that provides detailed assessment of plaque morphology, stent optimization and procedural complications during percutaneous coronary intervention (PCI). ...
Racial and ethnic differences and temporal changes in outcomes following transcatheter aortic valve replacement in urban hospitals [0.03%]
Rezwan Munshi,Sahil Ghay,Ralph Daher et al.
Rezwan Munshi et al.
Introduction: Transcatheter aortic valve replacement (TAVR) is an established treatment for severe aortic stenosis. Although TAVR has improved clinical outcomes, data on racial and ethnic differences in in-hospital clinic...
Novel lipid-lowering therapies versus statins in primary prevention of cardiovascular disease [0.03%]
新降脂疗法与他汀类药物在心血管疾病一级预防中的作用研究
Ramzi Ibrahim,Todd A Laffaye,Abdul Hakim Almakadma et al.
Ramzi Ibrahim et al.
Background: Scarce evidence exists comparing clinical outcomes of novel lipid-lowering monotherapy with standard statin therapy for primary prevention. We compared clinical outcomes among primary prevention patients treat...